ziprasidone has been researched along with dihydralazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, Z; Ding, H; Du, D; Liu, J; Luo, C; Sun, Z; Wang, M; Wu, Q | 1 |
2 other study(ies) available for ziprasidone and dihydralazine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay.
Topics: Aspartate Aminotransferase, Cytoplasmic; Cell Line, Tumor; Cell Proliferation; High-Throughput Screening Assays; Hydralazine | 2022 |